PharmaBoardroom

Lorenzo Ambrosini – CEO, Agire Foundation, Switzerland

Lorenzo Ambrosini of the Agire Foundation introduces the major new innovation projects underway in the Italian-speaking Swiss canton of Ticino; the…

Medtech’s Post-COVID Paradigm in APAC

At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic.…

MEA: Pfizer’s Saudi Transformation; Urgent Call for Arab Import…

The latest news from Middle East & North African pharma, including Pfizer’s transformation of its Saudi operations; why India is calling for…

New Drug Approvals in China 2020

The Chinese NMPA’s drug approval list for 2020 includes a surge in approvals for locally developed drugs. A total of 46 new drugs were approved in…

Ans Heirman – AVP Managing Director, MSD Switzerland

Switzerland is a crucial country for MSD’s global network, employing over 1000 people in local, regional, and global functions across four sites in…

NORD Chief Strategy Officer on Health Equity’s Vital…

With Rare Disease Day coming up on February 28th, one of the leading organizations dedicated to serving affected patients in the US, the National…

Top 5 Global CDMOs

As the global pharmaceutical industry continues to grow, so have opportunities for service providers. Over the last few decades, while big pharma…

STADA’s Bold Bets on M&A

After a year of growth and acquisitions, 125-year-old German generics manufacturer STADA is showing a willingness to make bold bets on areas including…

Securing the Conditions to Secure Our Meds

The AAM’s Dan Leonard highlights the savings impact that generic and biosimilar medicines have on US healthcare today and introduces the ‘Secure…

Lance Little – Managing Director (Asia Pacific), Roche…

Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical Technology Association (APACMed),…

Thomas A. Tóth von Kiskér – CEO & Board Member,…

Thomas A. Tóth von Kiskér, longstanding CEO of Tillotts Pharma AG, a Switzerland-based specialty pharma player focused on the digestive system,…

IFPMA’s Thomas Cueni on why “#TeamVaccines is all of…

Thomas Cueni of the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) highlights the incredible progress of COVID-19…

Tagged with